喜炎平在急性呼吸道感染患儿中的应用效果

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the application effect of Xiyanping in children with acute respiratory tract infection.Methods From February 2020 to May 2021,96 children with acute respiratory infection admitted to the Department of Pediatrics of Tianshui Maternal and Child Health Hospital were selected as the research objects,and they were divided into the experimental group (n=48) and the control group (n=48) using the random number table method (n=48).The experimental group was treated with Xiyanping Injection,and the control group was treated with Clohexine Dry Suspension.The treatment effect,clinical symptoms,inflammatory indicators and incidence of adverse reactions between the two groups were compared.Results The total effective rate of treatment in children in the experimental group was higher than that in the control group,and the difference was statistically significant (P＜0.05).The disappearance time of cough,fever,sore throat,nasal congestion,and pulmonary rales in the experimental group were shorter than those in the control group,the differences were statistically significant (P＜0.05).After treatment,the levels of serum interleukin-6 (IL-6),interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) were lower than those of the control group,and the differences were statistically significant (P＜0.05).There was no significant difference in the incidence of adverse reactions between the two groups.Conclusion Xiyanping Injection is effective in the treatment of children with acute respiratory tract infection and can quickly curb children′s cough and other clinical symptoms.The mechanism of action may be related to the reduction of inflammatory factors IL-6,IL-1β and TNF-α levels in children.

Key words： Xiyanping Acute respiratory infection Inflammatory factors Adverse reaction

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LU Mingcheng
	QIN Xuan
	XUE Hongyan

Cite this article:

LU Mingcheng,QIN Xuan,XUE Hongyan. Application effect of Xiyanping in children with acute respiratory tract infection[J]. 中国当代医药, 2022, 29(17): 119-122.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I17/119

[1]	刘玉林，黄晓楠，黄雪梅，等.2015-2017年川中地区儿童急性呼吸道感染病原学分析[J].检验医学与临床，2019，16（2）：191-193.
[2]	黄萍.儿童急性呼吸道感染病毒研究进展[J].中国病毒病杂志，2019，9（1）：69-75.
[3]	师美玲，吴国丽，薛丹，等.儿童上呼吸道感染中成药中西药联用的现状调查分析[J].中国药物与临床，2019，19（13）：2280-2281.
[4]	苏建华，闫虹.小儿金翘颗粒治疗小儿急性上呼吸道感染的临床研究[J].西北药学杂志，2020，35（2）：299-303.
[5]	王志飞，张洪春，谢雁鸣，等.喜炎平注射液治疗呼吸系统感染性疾病临床应用专家共识（成人版）[J].中国中药杂志，2019，44（24）：5282-5286.
[6]	冯益真.实用小儿呼吸病学[M].北京：中国协和医科大学出版社，2006：21-23.
[7]	刘全慧，张喜莲，马融，等.《中医药单用/联合抗生素治疗小儿急性上呼吸道感染临床实践指南》临床应用评价与修订意见[J].中国中药杂志，2018，43（24）：4753-4758.
[8]	周欣，汤纯洁，张燕玲.急性上呼吸道感染患者病毒流行病学特征分析[J].公共卫生与预防医学，2021，32（1）：105-108.
[9]	任波，李瑞丽，袁晓峰.两种药物治疗小儿急性呼吸道感染对患儿血清CRP PA 和IL-6 水平的影响比较[J].河北医学，2021，27（2）：339-343.
[10]	高燕敏.克洛己新干混悬剂治疗急性上呼吸道感染患儿的临床疗效及对血清炎症因子的影响[J].中国妇幼保健，2018，33（21）：4918-4921.
[11]	董叶青，董春富，陶兴和，等.综合医院儿童呼吸道感染流感嗜血杆菌的流行现状及耐药性分析[J].中国卫生检验杂志，2019，29（16）：35-37.
[12]	刘丰，李敏，张凡，等.中医治未病推拿干预小儿反复呼吸道感染专家共识[J].世界中西医结合杂志，2020，15（4）：767-769.
[13]	刘霞，沈红，星学花，等.小儿金翘颗粒联合喜炎平注射液治疗小儿上呼吸道感染的临床疗效研究[J].中华中医药学刊，2019，37（9）：2133-2136.
[14]	赵琨，杨德兴，蒋国云，等.细胞因子在诊断感染性疾病及其严重程度中的价值[J].昆明医科大学学报，2020，41（10）：101-107.
[15]	肖婧，应晶，李梅.小儿急性呼吸道感染的病原菌分布构成与耐药性分析及PTC、IL-6 表达水平的辅助诊断价值[J].中国妇幼保健，2019，34（18）：4243-4245.
[16]	何雯，毕良学，王宁玲.支气管哮喘患儿白介素、TNF-α与肺功能及免疫功能的关系研究[J].临床输血与检验，2020，22（6）：82-86.
[17]	杨利斌，杨林，王善坤，等.miR-155 对IL-1β 诱导髓核细胞凋亡、炎症和氧化应激的影响[J].安徽医科大学学报，2020，55（7）：1046-1051.
[18]	付平，刘冠彬，陈敬.喜炎平注射液联合小儿豉翘清热颗粒治疗急性上呼吸道感染患儿的临床疗效研究[J].实用心脑肺血管病杂志，2021，29（5）：85-91.